Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Trieu-Vu Nguyen"'
Autor:
Le Son Tran, Hong-Anh Thi Pham, Vu-Uyen Tran, Thanh-Truong Tran, Anh-Thu Huynh Dang, Dinh-Thong Le, Son-Lam Nguyen, Ngoc-Vu Nguyen, Trieu-Vu Nguyen, Binh Thanh Vo, Hong-Thuy Thi Dao, Nguyen Huu Nguyen, Tam Huu Tran, Chu Van Nguyen, Phuong Cam Pham, Anh Tuan Dang-Mai, Thien Kim Dinh-Nguyen, Van Hieu Phan, Thanh-Thuy Thi Do, Kiet Truong Dinh, Han Ngoc Do, Minh-Duy Phan, Hoa Giang, Hoai-Nghia Nguyen
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226193 (2019)
The identification and quantification of actionable mutations are of critical importance for effective genotype-directed therapies, prognosis and drug response monitoring in patients with non-small-cell lung cancer (NSCLC). Although tumor tissue biop
Externí odkaz:
https://doaj.org/article/d2c70cc813ba446987362f652e3f3ffe
Autor:
Hoai-Nghia Nguyen, Ngoc-Phuong Thi Cao, Thien-Chi Van Nguyen, Khang Nguyen Duy Le, Dat Thanh Nguyen, Quynh-Tho Thi Nguyen, Thai-Hoa Thi Nguyen, Chu Van Nguyen, Ha Thu Le, Mai-Lan Thi Nguyen, Trieu Vu Nguyen, Vu Uyen Tran, Bac An Luong, Linh Gia Hoang Le, Quoc Chuong Ho, Hong-Anh Thi Pham, Binh Thanh Vo, Luan Thanh Nguyen, Anh-Thu Huynh Dang, Sinh Duy Nguyen, Duc Minh Do, Thanh-Thuy Thi Do, Anh Vu Hoang, Kiet Truong Dinh, Minh-Duy Phan, Hoa Giang, Le Son Tran
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Targeted therapy with tyrosine kinase inhibitors (TKI) provides survival benefits to a majority of patients with non-small cell lung cancer (NSCLC). However, resistance to TKI almost always develops after treatment. Although genetic and epig
Externí odkaz:
https://doaj.org/article/74f63e07641a43ec9278ce5ec5a27f64
Autor:
Van Thien Chi Nguyen, Trong Hieu Nguyen, Nhu Nhat Tan Doan, Thi Mong Quynh Pham, Giang Thi Huong Nguyen, Thanh Dat Nguyen, Thuy Thi Thu Tran, Duy Long Vo, Thanh Hai Phan, Thanh Xuan Jasmine, Van Chu Nguyen, Huu Thinh Nguyen, Trieu Vu Nguyen, Thi Hue Hanh Nguyen, Le Anh Khoa Huynh, Trung Hieu Tran, Quang Thong Dang, Thuy Nguyen Doan, Anh Minh Tran, Viet Hai Nguyen, Vu Tuan Anh Nguyen, Le Minh Quoc Ho, Quang Dat Tran, Thi Thu Thuy Pham, Tan Dat Ho, Bao Toan Nguyen, Thanh Nhan Vo Nguyen, Thanh Dang Nguyen, Dung Thai Bieu Phu, Boi Hoan Huu Phan, Thi Loan Vo, Thi Huong Thoang Nai, Thuy Trang Tran, My Hoang Truong, Ngan Chau Tran, Trung Kien Le, Thanh Huong Thi Tran, Minh Long Duong, Hoai Phuong Thi Bach, Van Vu Kim, The Anh Pham, Duc Huy Tran, Trinh Ngoc An Le, Truong Vinh Ngoc Pham, Minh Triet Le, Dac Ho Vo, Thi Minh Thu Tran, Minh Nguyen Nguyen, Thi Tuong Vi Van, Anh Nhu Nguyen, Thi Trang Tran, Vu Uyen Tran, Minh Phong Le, Thi Thanh Do, Thi Van Phan, Luu Hong Dang Nguyen, Duy Sinh Nguyen, Van Thinh Cao, Thanh Thuy Thi Do, Dinh Kiet Truong, Hung Sang Tang, Hoa Giang, Hoai Nghia Nguyen, Minh Duy Phan, Le Son Tran
Despite their promise, circulating tumor DNA (ctDNA)-based assays for multi-cancer early detection face challenges in test performance, due mostly to the limited abundance of ctDNA and its inherent variability. To address these challenges, published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d711162bce03c4a6c14b9bc8be3e5fd
https://doi.org/10.1101/2023.04.12.23288460
https://doi.org/10.1101/2023.04.12.23288460
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Huu Thinh Nguyen, Le Anh Khoa Huynh, Trieu Vu Nguyen, Duc Huy Tran, Thuy Thi Thu Tran, Nguyen Duy Khang Le, Ngoc-An Trinh Le, Truong-Vinh Ngoc Pham, Minh-Triet Le, Thi Mong Quynh Pham, Trong Hieu Nguyen, Thien Chi Van Nguyen, Thanh Dat Nguyen, Bui Que Tran Nguyen, Minh-Duy Phan, Hoa Giang, Le Son Tran
Publikováno v:
Future oncology (London, England).
Aims: Early detection of colorectal cancer (CRC) provides substantially better survival rates. This study aimed to develop a blood-based screening assay named SPOT-MAS (‘screen for the presence of tumor by DNA methylation and size’) for early CRC
Autor:
Van‐Anh Nguyen Hoang, Sao Trung Nguyen, Trieu Vu Nguyen, Thanh Huyen Pham, Phuoc Loc Doan, Ngoc Thanh Nguyen Thi, Minh Long Nguyen, Thi Cuc Dinh, Dinh Hoang Pham, Ngoc Mai Nguyen, Duy Sinh Nguyen, Du Quyen Nguyen, Y‐Thanh Lu, Thanh Thuy Thi Do, Dinh Kiet Truong, Minh‐Duy Phan, Hoai‐Nghia Nguyen, Hoa Giang, Lan N. Tu
Publikováno v:
Molecular oncology.
Breast cancer is the leading cause of cancer death in Vietnamese women, but its mutational landscape and actionable alterations for targeted therapies remain unknown. After treatment, a sensitive biomarker to complement conventional imaging to monito
Autor:
Le Son Tran, Hong-Anh Thi Pham, Quynh-Tho Thi Nguyen, Binh Thanh Vo, Quoc Chuong Ho, Anh-Thu Huynh Dang, Thai-Hoa Thi Nguyen, Bac An Luong, Trieu Vu Nguyen, Linh Gia Hoang Le, Vu Uyen Tran, Thanh-Thuy Thi Do, Duc Minh Do, Kiet Truong Dinh, Minh-Duy Phan, Khang Nguyen Duy Le, Luan Thanh Nguyen, Ha Thu Le, Mai-Lan Thi Nguyen, Anh Vu Hoang, Chu Van Nguyen, Sinh Duy Nguyen, Dat Thanh Nguyen, Thien-Chi Van Nguyen, Hoai-Nghia Nguyen, Ngoc-Phuong Thi Cao, Hoa Giang
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Targeted therapy with tyrosine kinase inhibitors (TKI) provides survival benefits to a majority of patients with non-small cell lung cancer (NSCLC). However, resistance to TKI almost always develops after treatment. Although genetic and epigenetic al
Autor:
Chu Van Nguyen, Anh-Thu Huynh Dang, Hong-Thuy Thi Dao, Son-Lam Vu Nguyen, Phuong Cam Pham, Le Son Tran, Thanh-Truong Tran, Hong-Anh Thi Pham, Dinh-Thong Vu Le, Thanh-Thuy Thi Do, Trieu-Vu Nguyen, Vu-Uyen Tran, Kiet Truong Dinh, Tam Tran, Thien Kim Dinh-Nguyen, Hoa Giang, Anh Tuan Dang-Mai, Nguyen Huu Nguyen, Binh Thanh Vo, Hoai-Nghia Nguyen, Van Hieu Phan, Minh-Duy Phan, Ngoc-Vu Vu Nguyen, Han Ngoc Do
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0226193 (2019)
PLoS ONE
PLoS ONE
The identification and quantification of actionable mutations are of critical importance for effective genotype-directed therapies, prognosis and drug response monitoring in patients with non-small-cell lung cancer (NSCLC). Although tumor tissue biop
Autor:
Van‐Anh Nguyen Hoang, Sao Trung Nguyen, Trieu Vu Nguyen, Thanh Huyen Pham, Phuoc Loc Doan, Ngoc Thanh Nguyen Thi, Minh Long Nguyen, Thi Cuc Dinh, Dinh Hoang Pham, Ngoc Mai Nguyen, Duy Sinh Nguyen, Du Quyen Nguyen, Y‐Thanh Lu, Thanh Thuy Thi Do, Dinh Kiet Truong, Minh‐Duy Phan, Hoai‐Nghia Nguyen, Hoa Giang, Lan N. Tu
Publikováno v:
Molecular Oncology, Vol 17, Iss 4, Pp 598-610 (2023)
Breast cancer is the leading cause of cancer death in Vietnamese women, but its mutational landscape and actionable alterations for targeted therapies remain unknown. After treatment, a sensitive biomarker to complement conventional imaging to monito
Externí odkaz:
https://doaj.org/article/cb65bfefe411467fa96cfb5e19731f46